EP 51: Industry Pathway, Misconceptions & Perspectives with Dr Sameer Bansilal

Parallax by Ankur Kalra

Dr. Bansilal was an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai when he decided to seek out an alternative pathway to make an impact on patients’ lives. Dr. Ankur Kalra’s guest this week is Dr. Sameer Bansilal, Executive Director of U.S Medical Affairs of Cardiovascular and Renal at Bayer Pharmaceutical. After years with the TIMI Study Group, Sameer made the decision to leave academic medicine to join the pharmaceutical industry. He was not alone with this career move; Dr. Jessica Mega had just joined Google Life Sciences and Dr. Laura Mauri became the Vice President of Medtronic. The image of being a physician at pharma was going through a change. In this informative and honest conversation, Sameer shares his personal journey and the transformation that his new job required. Ankur and Sameer talk about expanding our views and our pilgrimage as readers. Ankur asks Sameer about the positive and negative aspects of his current job. Sameer addresses some of the preconceptions related to physicians working for the industry and shares his advice for early and mid-career cardiologists who are considering this option. Questions and comments can be sent to “[e-mail]” and may be answered by Ankur in the next episode. Guest @GarimaVSharmaMD, hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO. Brought to you by Edwards: www.edwardstavr.com